Gaboune L, Baha Ali T, Benfdil N, Khoumiri R, Ouaggag B, Sayouti A, Moutaouakil A
Service d'ophtalmologie, hôpital Mère-Enfant, CHU Mohamed VI, BP 2360, avenue Ibn Sina Ammerchich, Marrakech, Maroc.
J Fr Ophtalmol. 2012 Nov;35(9):718.e1-4. doi: 10.1016/j.jfo.2012.06.010. Epub 2012 Sep 12.
Kearns-Sayre syndrome (KSS), first described in 1958, is a multisystem disease defined by a characteristic triad of progressive external ophthalmoplegia, pigmentary retinopathy and atrioventricular block. These signs are frequently associated with increased cerebrospinal fluid protein level and cerebellar ataxia. This syndrome is caused by deletions in mitochondrial DNA, the age of onset is generally below 20, and the degree of severity differs between patients, as well as the prognosis, which may be fatal. The ocular manifestations include: bilateral ptosis, progressive external ophthalmoplegia and atypical pigmentary retinopathy. By way of this case report, the authors discuss the epidemiologic, clinical and therapeutic aspects of KSS, including the difficulty in managing ptosis in these cases.
卡恩斯-塞尔综合征(KSS)于1958年首次被描述,是一种多系统疾病,由进行性眼外肌麻痹、色素性视网膜病变和房室传导阻滞这一特征性三联征所定义。这些体征常伴有脑脊液蛋白水平升高和小脑共济失调。该综合征由线粒体DNA缺失引起,发病年龄通常在20岁以下,患者之间的严重程度以及预后有所不同,可能是致命的。眼部表现包括:双侧上睑下垂、进行性眼外肌麻痹和非典型色素性视网膜病变。通过本病例报告,作者讨论了KSS的流行病学、临床和治疗方面,包括这些病例中上睑下垂的治疗难点。